Buy GSK Pharma; target of Rs 2234: Motilal Oswal

Motilal Oswal is bullish on GlaxoSmithKline Pharma and has recommended buy rating on the stock with a target of Rs 2234 in its March 1, 2012 research report.

March 02, 2012 / 12:57 IST

Motilal Oswal is bullish on GlaxoSmithKline Pharma and has recommended buy rating on the stock with a target of Rs 2234 in its March 1, 2012 research report.

first published: Mar 2, 2012 12:46 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Buy GSK Pharma; target of Rs 2234: Motilal Oswal

Motilal Oswal is bullish on GlaxoSmithKline Pharma and has recommended buy rating on the stock with a target of Rs 2234 in its March 1, 2012 research report.

GI